How does cough syrup work?

Wet-cough syrups work through combinations of three main mechanisms: mucolytics that break down the structure of mucus to make it thinner, expectorants that increase fluid in the airway to dilute mucus, and bronchodilators that relax airway muscle to widen the passage mucus needs to travel through [3,4]. Most branded wet-cough syrups in India combine two or three of these rather than relying on a single ingredient.

A mucolytic is a drug that breaks down the structure of mucus so it becomes thinner and easier for the airway's natural clearance mechanisms and coughing to move out [3]. Ambroxol and bromhexine are the two mucolytics most commonly used in Indian wet-cough syrups.

What is the difference between an expectorant and a mucolytic?

A mucolytic changes the structure of mucus to make it less sticky. An expectorant, like guaifenesin, instead increases the volume and water content of airway secretions, diluting the mucus rather than restructuring it [4,6]. The two mechanisms are often combined in the same syrup because they act on mucus viscosity from different directions.

Ascoril vs. Benadryl — what's the difference?

Ascoril (Expectorant) combines a mucolytic, expectorant, and bronchodilator (bromhexine, guaifenesin, terbutaline) with no antihistamine. Benadryl Cough Formula combines an antihistamine with two expectorants (diphenhydramine, ammonium chloride, sodium citrate) with no bronchodilator. They address overlapping but different symptom profiles — bronchospasm and mucus for Ascoril, allergy symptoms and mucus for Benadryl — and the appropriate choice depends on the specific presentation, which is a decision for a physician or pharmacist.

Is wet cough syrup safe for children?

Current CDSCO and paediatric guidance advises against routine use of over-the-counter cough and cold syrups in children under 4–5 years of age [9]. For older children, any use should be under a doctor's specific direction rather than self-medication. This article does not provide dosing guidance for any age group — follow your paediatrician's prescription and the product label exactly.

Wet Cough Syrups in India: Types, Brands & How They Work

Reviewed and updated on July 3, 2026 by our pharma QC/QA & regulatory affairs desk. This article is informational and does not replace advice from a physician or pharmacist. Nothing below is a dosing instruction — always follow the label, package insert, or your doctor’s prescription for how much to take.

How Cough Syrups Work: Wet vs. Dry Cough, Explained

Every cough syrup on a pharmacy shelf is built around one question the formulator has to answer first: is this cough productive or non-productive? Get that wrong and the syrup can actively work against the body.

A wet cough (also called a productive or chesty cough) happens when the airways are producing excess mucus — usually from a viral infection, bronchitis, or allergy — and the cough reflex is the body’s way of clearing that mucus out. A dry cough is a tickly, reflexive cough with little or no mucus, often from throat irritation, post-viral airway sensitivity, or acid reflux.

This distinction drives formulation. For a dry cough, the pharmacological goal is usually to suppress the cough reflex (an antitussive approach). For a wet cough, suppressing the reflex is generally the wrong move — the mucus still needs to come out, so a dry-cough suppressant can leave it trapped in the airway. Wet-cough formulations instead focus on making mucus thinner (mucolytics), more mobile (expectorants), and on widening the airway so it can be cleared more easily (bronchodilators) [3,4]. That is why almost every branded “wet cough” syrup in India is a combination product built from two or three of these mechanisms rather than a single active ingredient — and it is also why a syrup formulated for dry cough is not simply interchangeable with one formulated for wet cough, regardless of what a search result or a well-meaning relative suggests.

How Wet Cough Syrup Works - Medical infographic showing four stages of mucolytic and expectorant action

Understanding Drug Classes: Mucolytics vs. Expectorants vs. Bronchodilators vs. Antitussives

Most patients — and a fair number of retail pharmacy counters — use “mucolytic” and “expectorant” interchangeably. They are related but pharmacologically distinct, and knowing the difference actually changes which syrup makes sense for which symptom picture. Here is how a QC/QA-trained eye reads a cough syrup’s composition panel.

Mucolytics

Mucolytics act directly on the structure of mucus, breaking down the polymer network that gives thick phlegm its stickiness and viscosity [3]. Ambroxol and bromhexine, the two mucolytics you’ll see most often in Indian wet-cough syrups, work on this principle while also stimulating ciliary movement in the airway lining [3,4]. The result is thinner, less viscous mucus that the body’s own cough reflex and cilia can move out more easily. Ambroxol is, in fact, the active metabolite of bromhexine — so syrups built around either one are working through a closely related mechanism, just at different points in the metabolic pathway.

Expectorants

Expectorants work by a different route: they increase the volume and water content of respiratory secretions, which reduces mucus viscosity by dilution rather than by breaking its structure down [4,6]. Guaifenesin is the expectorant used in almost every branded combination syrup in this category, and it is rarely sold on its own as a single-ingredient syrup in the Indian market — it is used to reduce the stickiness of mucus, and it is nearly always paired with a mucolytic and/or a bronchodilator in the country’s leading brands. Ammonium chloride and sodium citrate are older-generation expectorants that work on a similar principle and still appear in long-standing formulations.

Bronchodilators

Bronchodilators don’t touch the mucus itself — they relax the smooth muscle around the airway, widening it so air (and loosened mucus) can move more freely, which is why they’re commonly added alongside mucolytics and expectorants as part of a broader airway-clearance strategy rather than used to act on secretions directly [4]. Levosalbutamol, salbutamol, and terbutaline are the beta-2 agonists most commonly combined into wet-cough syrups, particularly where there’s a component of bronchospasm alongside the mucus — for example in bronchitis or in patients with an asthmatic tendency. This is also why several wet-cough combinations carry cardiac and thyroid precautions on the label: beta-2 agonists can increase heart rate and are used cautiously in patients with pre-existing heart or thyroid conditions.

Antitussives (and why they’re largely absent from this list)

Dextromethorphan and, in some older formulations, codeine-based agents are antitussives — they act centrally on the brain’s cough centre to reduce the urge to cough altogether. This is the right tool for a dry, irritating cough with no mucus to clear. It is generally the wrong tool for a wet cough, because suppressing the reflex can leave mucus sitting in the airway. That’s a large part of why you won’t find pure antitussives among the leading wet-cough brands below — and why combining an antitussive with an expectorant in the same formulation is considered pharmacologically counterproductive.

Antihistamines

A smaller group of wet-cough syrups, Benadryl Cough Formula being the best-known example in India, add a first-generation antihistamine such as diphenhydramine. This doesn’t act on mucus directly; it blocks histamine to reduce allergy-driven symptoms — runny nose, sneezing, watery eyes — that often accompany a cough, and it carries a sedative side effect that some formulations lean into for night-time use.

Quick reference — what each class actually does:

Mucolytic (ambroxol, bromhexine) — breaks down mucus structure, makes it less sticky [3,4]
Expectorant (guaifenesin, ammonium chloride, sodium citrate) — increases fluid volume, dilutes mucus [4,6]
Bronchodilator (levosalbutamol, salbutamol, terbutaline) — relaxes and widens the airway
Antitussive (dextromethorphan) — suppresses the cough reflex centrally; for dry cough, not wet cough
Antihistamine (diphenhydramine) — blocks allergy-driven symptoms; sedating

An Honest Note on the Evidence

This is the part most consumer cough-syrup content skips, and as a QC/QA-credentialed author we’d rather say it plainly than let the omission stand in for a claim we can’t back up: the best available systematic evidence on over-the-counter cough medicines for acute cough — a Cochrane systematic review — found no good evidence either for or against their effectiveness, in either children or adults, across the OTC categories it examined [5,7]. That finding has held up across multiple update cycles of the review, and it echoes a much older observation in the literature that the rationale behind expectorants has long outpaced the clinical proof supporting it [6].

This doesn’t mean these medicines don’t help — symptom relief is real and widely reported by patients, and the pharmacological mechanisms described above are genuine and well characterised. It means the evidence bar for “this specific combination clearly shortens or reduces your cough” is lower than the confidence with which OTC cough syrups are often marketed. We’d rather flag that honestly than overstate it, because overstating proof of efficacy is a bigger credibility risk for a page like this than acknowledging the limits of what’s been formally studied.

Top Wet Cough Syrups in India: What’s Actually in Them

Cough syrup combinations of this kind are regulated as prescription medicines in India, governed by the Drugs and Cosmetics Rules under the oversight of the Central Drugs Standard Control Organisation (CDSCO), with composition and quality standards set by the Indian Pharmacopoeia Commission (IPC) [1,2]. The table below covers the most widely searched and prescribed wet-cough combination brands in the Indian market, with composition per 5 ml as listed on manufacturer and pharmacy-reference sources at the time of review. Every one of these is a prescription medicine — none should be started, stopped, or dosed without a doctor’s or pharmacist’s direction, and none should be given to a child without medical guidance.

A note on what you’ll notice in this list: several “different” brands below share the exact same active-ingredient combination in the exact same strengths. That isn’t a coincidence — it’s how India’s branded-generics market works. Ambroxol 30 mg + Levosalbutamol 1 mg + Guaifenesin 50 mg, for instance, is sold under at least three major brand names by three different manufacturers. Pharmacologically, they are the same medicine with different labels.

Wet Cough Syrup Directory · India

Cough Syrup Type & Brand Finder

Filter by drug class or cough type to see which named brands fall into which pharmacological category. Composition data is per 5 ml as listed on manufacturer/regulatory-adjacent sources. This is not a purchase recommendation — confirm any product against your prescription with a physician or pharmacist.

Prescription status shown reflects Schedule H/G labelling where confirmed on manufacturer sources, or general prescription-required status where the specific schedule letter was not independently confirmed. All products listed require a valid prescription in practice. Consult a physician or pharmacist before use — this directory does not provide dosing guidance.

1. Ascoril LS Syrup — Glenmark Pharmaceuticals

Composition: Ambroxol 30 mg + Levosalbutamol 1 mg + Guaifenesin 50 mg per 5 ml.
A triple-action mucolytic–bronchodilator–expectorant, and one of the most searched wet-cough brands in India. Used for productive cough associated with bronchitis and chest congestion. Prescription-only (Schedule H). Consult a physician or pharmacist before use.

2. Grilinctus-LS Syrup — Franco-Indian Pharmaceuticals

Composition: Ambroxol 30 mg + Levosalbutamol 1 mg + Guaifenesin 50 mg per 5 ml.
The same triple combination as Ascoril LS, from a different manufacturer. Indicated for cough with mucus associated with bronchitis, asthma, and COPD. Prescription-only (Schedule H). Consult a physician or pharmacist before use.

3. Solvin-LS Syrup — Ipca Laboratories

Composition: Ambroxol 30 mg + Levosalbutamol 1 mg + Guaifenesin 50 mg per 5 ml.
A third brand built on the identical salt combination above. Indicated for productive cough with bronchospasm. Prescription required. Consult a physician or pharmacist before use.

4. Grilinctus-BM Syrup — Franco-Indian Pharmaceuticals

Composition: Bromhexine 8 mg + Terbutaline 2.5 mg per 5 ml.
A two-component mucolytic–bronchodilator combination without an added expectorant. Used for wet cough associated with bronchial asthma, bronchitis, and other airway conditions involving both mucus and bronchospasm. Prescription required. Consult a physician or pharmacist before use.

5. Ambrodil-S Syrup — Aristo Pharmaceuticals

Composition: Ambroxol 15 mg + Salbutamol 1 mg per 5 ml.
A mucolytic–bronchodilator pairing at a lower ambroxol strength than the LS brands above, commonly used in bronchitis, asthma with mucus, and COPD. Prescription required. Consult a physician or pharmacist before use.

6. Benadryl Cough Formula — JNTL Consumer Health (Johnson & Johnson)

Composition: Diphenhydramine 14.08 mg + Ammonium Chloride 138 mg + Sodium Citrate 57.03 mg per 5 ml.
Structurally different from the ambroxol-based brands above: this is an antihistamine-plus-expectorant combination rather than a mucolytic-bronchodilator one. Marketed for cough accompanied by allergy symptoms — runny nose, sneezing, watery eyes — as well as chest congestion. Prescription-only (Schedule G on the manufacturer’s own labelling). Consult a physician or pharmacist before use.

7. Alkof Syrup — Cipla Health

Composition: Bromhexine 2 mg + Guaifenesin 50 mg + Terbutaline 1.25 mg + Menthol 0.5 mg per 5 ml.
A four-component formulation combining a mucolytic, expectorant, and bronchodilator with menthol for throat-soothing effect. Used for wet cough linked to bronchitis and chest infections. Prescription-only (Schedule H). Consult a physician or pharmacist before use.

8. Ascoril Expectorant — Glenmark Pharmaceuticals

Composition: Bromhexine 4 mg + Guaifenesin 50 mg + Terbutaline 1.25 mg per 5 ml.
A related but distinct formulation from Ascoril LS — same brand family, different active-ingredient combination, built around bromhexine and terbutaline rather than ambroxol and levosalbutamol. This is worth flagging specifically because “Ascoril” and “Ascoril LS” are frequently confused as the same product; they are not. Prescription required. Consult a physician or pharmacist before use.

Brand vs. Brand: How the Most-Compared Wet Cough Syrups Differ

A large share of the searches that bring people to pages like this one aren’t “what’s the best cough syrup” — they’re “I have Brand A in my hand, my chemist gave me Brand B instead, are they the same thing?” Below is a factual comparison of the pairings we see searched most. This is composition information, not a recommendation of one brand over another — that decision belongs to your doctor or pharmacist, based on your specific symptoms and medical history.

Brand vs. Brand · Composition Only

Cough Syrup Brand Comparison Tool

Pick any two brands to compare active ingredients, drug class, and indicated use side by side. This tool presents composition facts only — it does not recommend one brand over another. Confirm any switch with a physician or pharmacist.

Brand A

Brand B

Composition shown is per 5 ml as listed on manufacturer/regulatory-adjacent sources at time of review and may vary by pack size or formulation update. All products listed are prescription medicines. This comparison is informational only, is not a substitute for professional medical advice, and does not constitute a recommendation to switch, combine, or discontinue any medicine. Always confirm with a physician or pharmacist before use.

Ascoril LS vs. Grilinctus LS

Identical composition: Ambroxol 30 mg + Levosalbutamol 1 mg + Guaifenesin 50 mg per 5 ml, in both cases. The difference between them is the manufacturer (Glenmark vs. Franco-Indian) and price point, not the pharmacology. If a pharmacist substitutes one for the other, they are dispensing the same medicine under a different brand name — this is standard branded-generic substitution in India, not an error, provided the strength matches your prescription.

Ascoril vs. Benadryl

These are genuinely different formulations, not brand variants of the same combination. Ascoril Expectorant is built on bromhexine (mucolytic) + guaifenesin (expectorant) + terbutaline (bronchodilator) — no antihistamine. Benadryl Cough Formula is built on diphenhydramine (antihistamine) + ammonium chloride and sodium citrate (expectorants) — no bronchodilator. Ascoril leans toward airway-widening and mucus-thinning; Benadryl leans toward allergy-symptom control alongside mucus thinning, and carries a stronger sedation profile because of the antihistamine component. Which is appropriate depends on whether bronchospasm or allergic symptoms are the dominant issue — a distinction for your physician to make, not a home diagnosis.

Benadryl vs. Grilinctus

The same underlying contrast applies here: Benadryl’s antihistamine-plus-expectorant combination versus Grilinctus-LS’s mucolytic-bronchodilator-expectorant triple combination (or Grilinctus-BM’s mucolytic-bronchodilator pairing, depending on which “Grilinctus” variant is meant — the brand name covers more than one composition, which is itself a common source of confusion at the pharmacy counter). Neither is a direct substitute for the other; they target overlapping but distinct symptom profiles.

Ambrodil-S vs. Ascoril LS

Both are mucolytic-bronchodilator combinations built on the ambroxol/salbutamol family, but they are not identical. Ambrodil-S uses ambroxol 15 mg + salbutamol 1 mg with no added expectorant; Ascoril LS uses ambroxol 30 mg (double the strength) + levosalbutamol 1 mg + guaifenesin 50 mg, adding an expectorant that Ambrodil-S does not contain. The strength difference and the presence or absence of guaifenesin are the two things a pharmacist or physician would weigh when choosing between them.

On “alternatives” and substitutions generally

If your regular brand is out of stock, a chemist will often offer an “alternative” with the same salts — that’s a legitimate, common practice. What is not advisable is self-substituting across genuinely different compositions (for example, swapping a bronchodilator combination for an antihistamine combination) based on price or availability alone. If you’re ever unsure whether a substitute is a true match or a different formulation, ask the pharmacist to confirm the composition against your prescription, or check with your doctor.

Regulatory Context: Why Composition Accuracy in This Category Matters Right Now

This isn’t an abstract compliance point. In October 2025, the World Health Organization issued a medical product alert after India’s CDSCO confirmed that specific batches of three oral liquid medicines — including a paediatric cough-and-cold syrup called Coldrif, manufactured by Sresan Pharmaceuticals — were contaminated with diethylene glycol (DEG), an industrial solvent, at concentrations vastly above the permissible pharmacopoeial limit [8]. The contamination was linked to multiple child deaths and led to plant shutdowns, license suspensions, and a nationwide CDSCO directive on batch-level raw-material testing. This followed an earlier, separate December 2023 CDSCO restriction on a different anti-cold fixed-dose combination (chlorpheniramine maleate + phenylephrine) in children under four, issued after cough-syrup-linked child deaths in the Gambia and elsewhere were traced to Indian-manufactured products [9].

None of the syrups profiled in this article have been implicated in either incident. We’re flagging this for a specific reason: it’s why regulatory bodies and most paediatricians now advise against using over-the-counter cough and cold syrups in children under 4–5 years of age for routine cough, why every combination product on this page carries a “consult a physician” line rather than a home dosage guide, and why buying from a licensed pharmacy — where batch provenance and cold-chain/storage conditions are traceable — is not a formality. If a syrup smells, tastes, or looks different from a previous bottle of the same brand, that is a reason to stop and contact your pharmacist, not to continue the course.

Frequently Asked Questions

How does cough syrup work?

Wet-cough syrups work through combinations of three main mechanisms: mucolytics that break down the structure of mucus to make it thinner, expectorants that increase fluid in the airway to dilute mucus, and bronchodilators that relax airway muscle to widen the passage mucus needs to travel through [3,4]. Most branded wet-cough syrups in India combine two or three of these rather than relying on a single ingredient.
What is a mucolytic?

A mucolytic is a drug that breaks down the structure of mucus so it becomes thinner and easier for the airway’s natural clearance mechanisms and coughing to move out [3]. Ambroxol and bromhexine are the two mucolytics most commonly used in Indian wet-cough syrups.
What is the difference between an expectorant and a mucolytic?

A mucolytic changes the structure of mucus to make it less sticky. An expectorant, like guaifenesin, instead increases the volume and water content of airway secretions, diluting the mucus rather than restructuring it [4,6]. The two mechanisms are often combined in the same syrup because they act on mucus viscosity from different directions.
Ascoril vs. Benadryl — what’s the difference?

Ascoril (Expectorant) combines a mucolytic, expectorant, and bronchodilator (bromhexine, guaifenesin, terbutaline) with no antihistamine. Benadryl Cough Formula combines an antihistamine with two expectorants (diphenhydramine, ammonium chloride, sodium citrate) with no bronchodilator. They address overlapping but different symptom profiles — bronchospasm and mucus for Ascoril, allergy symptoms and mucus for Benadryl — and the appropriate choice depends on the specific presentation, which is a decision for a physician or pharmacist.
Is wet cough syrup safe for children?

Current CDSCO and paediatric guidance advises against routine use of over-the-counter cough and cold syrups in children under 4–5 years of age [9]. For older children, any use should be under a doctor’s specific direction rather than self-medication. This article does not provide dosing guidance for any age group — follow your paediatrician’s prescription and the product label exactly.

This article is reviewed periodically by Laafon’s pharma QC/QA and regulatory affairs team based on peer-reviewed pharmacology literature, CDSCO/WHO advisories, and manufacturer product information. It is intended for general information only and is not a substitute for professional medical advice, diagnosis, or treatment. Branded-product composition details reflect standard 5 ml dosing as listed on manufacturer and pharmacy-reference sources at the time of review and may vary by pack size or formulation update — always confirm against the product label in hand or an authoritative source such as CIMS/MIMS India before publishing or acting on this information. Always consult a physician or pharmacist before starting, stopping, or combining any cough medicine, and never administer any cough syrup to a child without medical guidance.

References

Central Drugs Standard Control Organisation. Home [Internet]. New Delhi: Ministry of Health & Family Welfare, Government of India; [cited 2026 Jul 3]. Available from: https://cdsco.gov.in/
Indian Pharmacopoeia Commission. Home [Internet]. Ghaziabad: Ministry of Health & Family Welfare, Government of India; [cited 2026 Jul 3]. Available from: https://www.ipc.gov.in/
Gupta R, Wadhwa R. Mucolytic medications. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [updated 2023 Jul 4; cited 2026 Jul 3]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559163/
Rubin BK. The pharmacologic approach to airway clearance: mucoactive agents. Paediatr Respir Rev. 2006;7(Suppl 1):S215–9.
Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev. 2014;(11):CD001831.
Ziment I. What to expect from expectorants. JAMA. 1976;236(2):193–4.
Fogleman CD. Cochrane for clinicians: over-the-counter medications for acute cough symptoms. Am Fam Physician. 2008;78(1):52. Available from: https://www.aafp.org/pubs/afp/issues/2008/0701/p52.html
World Health Organization. Medical Product Alert N°5/2025: substandard (contaminated) oral liquid medicines [Internet]. Geneva: WHO; 2025 Oct 13 [cited 2026 Jul 4]. Available from: https://www.who.int/news/item/13-10-2025-medical-product-alert-n-5-2025–substandard-(contaminated)-oral-liquid-medicines
Business Today. Govt bans anti-cold drug combination for kids aged under four [Internet]. 2023 Dec 21 [cited 2026 Jul 4]. Available from: https://www.businesstoday.in/latest/in-focus/story/govt-bans-anti-cold-drug-combination-for-kids-aged-under-four-410317-2023-12-21